Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy

NCT04638088 · tracked via the Priya Life Science France tracker
Sponsor
Phase
Observational
Started
2021-03-08
Last updated
2026-04-21

Condition(s) studied

Prostate Cancer

Investigational drug(s) / intervention(s)

assessment of urinary function and erectil function before and after prostatectomy

assessment of urinary function and erectil function before and after prostatectomy: assessment of urinary function and erectil function before and after prostatectomy performed by robot assisted or conventional laparoscopy or laparotomy will complete

Study summary

Minimally invasive surgery has developed widely since the 1980s and has revolutionized the practices of surgeons. In urology, the development of laparoscopy and then robot-assisted surgery has considerably improved the management of pathologies. In France, as in all the countries concerned, the spread of robotic surgery has taken place without prior studies validating this new technology, nor organizational rules in terms of quality and access to care. The report of the Haute Autorité de Santé dated November 2016 underlines the weakness of the methodological quality of studies and meta-analyzes evaluating robot-assisted total prostatectomy compared to other surgical techniques by laparotomy or conventional laparoscopy. It therefore appears important to evaluate in a large study the interest of this technique in order to help the authorities to decide on the real benefit of this technology and to provide reliable answers to the patients.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patient hospitalized for a planned radical prostatectomy Exclusion Criteria: * Consent refusal from the patient * Patients protected by law (Art.L 1121-5, 1121-6, 1121-8 du Code de la santé publique) * Absence of a French Health Care Insurance coverage

Primary outcome measure(s)

  • Impact of the prostatectomy procedure (robot assisted laparoscopy, conventional laparoscopy and surgical laparotomy) on the urinary function assessed by the EPIC 50 score — 45 Days after the surgery
    Comparison of the prostatectomy performed by robot assisted laparoscopy or conventional laparoscopy and by surgical laparotomy on the urinary function assessed by the EPIC 50 score (Expanded Prostate Cancer Index Composite)

Trial sites (30)

FacilityCityRegionStatus
Clinique Esquirol Saint Hilaire Agen France Recruiting
Clinique Rhône Durance Avignon France Completed
Hôpital Privé La Châtaigneraie Beaumont France Completed
Clinique St Vincent Besançon France Completed
Polyclinique de Franche Comté Besançon France Completed
Clinique de Saint Augustin Bordeaux France Completed
Clinique Keraudren - CHPB Brest France Recruiting
Centre Médico-Chirurgical Les Cèdres Brive-la-Gaillarde France Recruiting
Polyclinique Médipôle Saint-Roch Cabestany France Completed
Polyclinique du Parc Caen France Completed
Polyclinique Montréal Carcassonne France Recruiting
Pôle Santé République Clermont-Ferrand France Recruiting
Hôpital Privé Saint-François Désertines France Withdrawn
Clinique Cap-d'Or La Seyne-sur-Mer France Completed
Pôle Santé Sud Le Mans France Completed
Clinique Emailleurs-Colombier Limoges France Recruiting
Polyclinique de Limoges Limoges France Completed
Clinique Claude Bernard Metz France Withdrawn
Polyclinique de Gentilly Nancy France Completed
Clinique Saint-Augustin Nantes France Completed
Polyclinique Grand Sud Nîmes France Completed
Polyclinique Les Fleurs Ollioules France Completed
Polyclinique de Poitiers Poitiers France Recruiting
Clinique du Renaison Roanne France Recruiting
Clinique Guillaume De Varye Saint-Doulchard France Completed
Centre clinical Soyaux France Completed
Clinique de l'Estrée Stains France Completed
Clinique Ambroise Paré Toulouse France Recruiting
Polyclinique Vauban Valenciennes France Completed
Hôpital privé Océane Vannes France Completed
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04638088 on ClinicalTrials.gov ↗ ← All trials in France